Fig. 2From: Clustering of HR + /HER2− breast cancer in an Asian cohort is driven by immune phenotypesComparison of MyBrCa clusters with a clinical subtypes, b immune scores and c Gene Set Variation Analysis (GSVA) scores. HR + clusters with high immune scores (Group 1) and low immune scores (Group 2) are identifiedBack to article page